At 4:56 a.m. EST (0956 GMT) on Feb. 17, the moon will begin to turn the sun into an impressive "ring of fire" during an ...

MUMBAI: The State Election Commission on Tuesday announced elections on Feb 5 to 12 zilla parishads and 125 panchayat samitis ...

Blue Origin’s New Glenn rocket at liftoff during the NG-2 mission on Nov. 13. Credit: Blue Origin The U.S. Space Force is now taking proposals from new launch providers with rockets ready to fly by ...

Fluor and JGC said Monday they had handed over LNG Canada's second production train, bringing the Shell-led project's capacity to 14 million tons a year. Image by MikeMareen via iStock Fluor Corp and ...

– Oral and poster presentations to include seizure and neurodevelopmental data from POLARIS Phase 1/2 Program that support advancement of ETX101 – SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...

Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...

Capsida Biotherapeutics has paused a gene therapy trial after the first patient died. The biotech, which began the phase 1/2 study in July, took the action to give it time to determine the “root cause ...

Phase 1 of S-100 Standards implementation is now complete after the operational release of standards S-124 Navigational Warnings and S-128 Catalogue of Nautical Products. The S-100 framework is a new ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook In the years since, the franchise has changed considerably. The MCU movies of 2025 have brought ...

Warning: This piece contains full spoilers for The Fantastic Four: First Steps. But most of all, First Steps gives us something we haven’t seen from the MCU in a long time: a throwback to the Phase 1 ...

LEWES, DE - The Delaware Department of Transportation (DelDOT) has announced Phase 1 construction for the State Route 1 (SR1) and Minos Conaway Rd. Intersection Project near Lewes. DelDOT says the SR1 ...

Neumora Therapeutics, Inc. has announced the initiation of a Phase 1 study for NMRA-861, a potent and selective positive allosteric modulator of the M4 muscarinic receptor, aimed at treating ...